Skip to main navigation Skip to search Skip to main content

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

  • for the NILVAD Study Group
  • Trinity College Dublin, St James's Hospital
  • Trinity College Dublin
  • University College Dublin
  • Tallaght Hospital
  • Radboud University Nijmegen
  • University College London
  • Université de Lille
  • University of Gothenburg
  • Aristotle University of Thessaloniki
  • IRCCS Istituto di ricerche farmacologiche Mario Negri - Milano, Bergamo, Ranica
  • University College Cork
  • Ulm University
  • University of Szeged
  • King's College London
  • Pentara Corporation
  • University of Southern California
  • Molecular Medicine Ireland (MMI)
  • Rijnstate Hospital
  • Maastricht University
  • IRCCS Fondazione Don Carlo Gnocchi - Milano
  • University of Genoa
  • Hospital San Martino
  • IRCCS Multimedica - Milano
  • IRCCS Centro San Giovanni di Dio Fatebenefratelli - Brescia
  • Centre Hospitalier de Calais
  • Université de Caen
  • Centre Hospitalier de LENS
  • Centre Hospitalier de Béthune
  • Centre Hospitalier Universitaire d'Amiens
  • Université catholique de Lille
  • Archer Pharmaceuticals Inc
  • Roskamp Institute

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology